N-(1-(3-(4-ETHYL-5-OXO-TETRAZOL-1-YL)PROPYL)-4-PIPERIDYL)-N-PHENYL-PROPANAMIDE

CCN1N=NN(CCCN2CCC(CC2)N(C(=O)CC)C3=CC=CC=C3)C1=O

InChIKey=XBKTWPHAGMBVJQ-UHFFFAOYSA-N

InChI=1S/C20H30N6O2/c1-3-19(27)26(17-9-6-5-7-10-17)18-11-15-23(16-12-18)13-8-14-25-20(28)24(4-2)21-22-25/h5-7,9-10,18H,3-4,8,11-16H2,1-2H3

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Substance Class	Chemical Created by `admin` on `Sat Dec 16 13:24:28 GMT 2023` Edited by `admin` on `Sat Dec 16 13:24:28 GMT 2023`
Record UNII	ZE556RX3QA
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

N-(1-(3-(4-ETHYL-5-OXO-TETRAZOL-1-YL)PROPYL)-4-PIPERIDYL)-N-PHENYL-PROPANAMIDE

Systematic Name

English

PROPANAMIDE, N-(1-(3-(4-ETHYL-4,5-DIHYDRO-5-OXO-1H-TETRAZOL-1-YL)PROPYL)-4-PIPERIDINYL)-N-PHENYL-

Systematic Name

English

Code System Code Type Description

PUBCHEM

13676725

Created by admin on Sat Dec 16 13:24:28 GMT 2023 , Edited by admin on Sat Dec 16 13:24:28 GMT 2023

PRIMARY

CAS

104072-09-5

Created by admin on Sat Dec 16 13:24:28 GMT 2023 , Edited by admin on Sat Dec 16 13:24:28 GMT 2023

PRIMARY

FDA UNII

ZE556RX3QA

Created by admin on Sat Dec 16 13:24:28 GMT 2023 , Edited by admin on Sat Dec 16 13:24:28 GMT 2023

PRIMARY

Related Record Type Details


					RD5NDX6QJL

SALT/SOLVATE -> PARENT

Comments:

Morphinomimetic activity, after IV injection, in rats was evaluated by the tail withdrawal reflex test. ED50(mg/kg) = >2.5 at peak effect.

Amount:


					1N74HM2BS7

PARENT -> DERIVATIVE

Amount: